Literature DB >> 31201628

Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.

A E Mamedov1, M Yu Zakharova2,3, O O Favorova3, O G Kulakova3, A N Boyko3, V D Knorre4, N A Vorobieva5, E N Khurs6, I S Kiselev3, N M Baulina3, A G Gabibov2,7, A A Belogurov2,7.   

Abstract

Genetic analysis of thousands of patients with multiple sclerosis (MS) and healthy Russian donors showed that the carriage of groups of HLA-DRB1*15 and HLA-DRB1*03 alleles is associated with the risk of MS, whereas the carriage of groups of HLA-DRB1*01 and HLA-DRB1*11 alleles is protective. Recombinant HLA-DRB1*01:01 with a high affinity can recognize the fragments of myelin basic protein (MBP), one of the autoantigens in MS. However, the comparison of the kinetic parameters of the load of MBP and viral HA peptides on HLA-DRB1*01:01, which is catalyzed by HLA-DM, showed a significantly lower rate of exchange of CLIP for MBP peptides. We assume that the observed protective properties of the group of HLA-DRB1*01 alleles may be directly associated with the ability of HLA-DRB1*01:01 to kinetically distinguish peptides of exogenous and endogenous nature.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31201628     DOI: 10.1134/S1607672919020078

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  8 in total

Review 1.  Multiple sclerosis genetics.

Authors:  Ester Canto; Jorge R Oksenberg
Journal:  Mult Scler       Date:  2018-01       Impact factor: 6.312

2.  [Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene].

Authors:  M A Sudomoina; A N Boĭko; T L Demina; E I Gusev; M N Boldyreva; D Iu Trofimov; L P Alekseev; O O Favorova
Journal:  Mol Biol (Mosk)       Date:  1998 Mar-Apr

3.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

4.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

5.  Formation of a highly peptide-receptive state of class II MHC.

Authors:  J D Rabinowitz; M Vrljic; P M Kasson; M N Liang; R Busch; J J Boniface; M M Davis; H M McConnell
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

6.  Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.

Authors:  Alexey A Belogurov; Inna N Kurkova; Alain Friboulet; Daniel Thomas; Viktor K Misikov; Maria Yu Zakharova; Sergey V Suchkov; Sergey V Kotov; Alexander I Alehin; Bérangère Avalle; Ekaterina A Souslova; Herbert C Morse; Alexander G Gabibov; Natalia A Ponomarenko
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

7.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

8.  Multiple sclerosis: major histocompatibility complexity and antigen presentation.

Authors:  Sreeram V Ramagopalan; George C Ebers
Journal:  Genome Med       Date:  2009-11-06       Impact factor: 11.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.